Cabot (NYSE:CBT) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Cabot (NYSE:CBT) released its quarterly earnings results on Monday. The specialty chemicals company reported $1.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01), Briefing.com reports. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $1.01 billion. During the same quarter last year, the firm posted $1.65 EPS. Cabot’s revenue for the quarter was up 3.7% on a year-over-year basis. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.

Cabot Stock Down 1.1 %

CBT stock traded down $1.19 during midday trading on Tuesday, hitting $108.90. The stock had a trading volume of 335,840 shares, compared to its average volume of 336,063. The business has a 50-day moving average of $108.30 and a two-hundred day moving average of $101.01. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45. The firm has a market cap of $5.97 billion, a price-to-earnings ratio of 13.09, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20. Cabot has a 52-week low of $66.02 and a 52-week high of $117.14.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 25,617 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the sale, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at $33,630,719.70. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Sean D. Keohane sold 25,617 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares of the company’s stock, valued at $33,630,719.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Erica Mclaughlin sold 23,274 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the sale, the chief financial officer now directly owns 59,814 shares in the company, valued at $5,968,839.06. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 71,939 shares of company stock valued at $7,308,812. 3.07% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts have commented on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. UBS Group reduced their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $101.75.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.